Considering the increase of the elderly population in recent years, the growing prevalence of age-related neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD) and Parkinson’s disease (PD), has become one of the leading healthcare problems. Currently, available therapies for AD and PD are still limited, while medicinal p...

By Ana Alimpić-Aradski, Mariana Oalđe-Pavlović, Smiljana Janković, Petar D.Marin, Sonja Duletić-Laušević